139.72
-7.72
(-5.24%)
At close: April 9 at 7:13:28 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 24 | 23 |
| Avg. Estimate | 1.85B | 1.95B | 8.14B | 8.65B |
| Low Estimate | 1.76B | 1.9B | 7.87B | 8.27B |
| High Estimate | 2.12B | 2.1B | 8.7B | 9.31B |
| Year Ago Sales | 1.6B | 1.76B | 7.55B | 8.14B |
| Sales Growth (year/est) | 15.57% | 10.72% | 7.85% | 6.25% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0QYD.L | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 4/8/2025 |
| Maintains | Baird: Outperform to Outperform | 4/7/2025 |
| Reiterates | TD Securities: Hold to Hold | 3/31/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 3/20/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/13/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/5/2025 |